Histomolecular classification of adult diffuse gliomas: The diagnostic value of immunohistochemical markers

Revue Neurologique

Volumn 167, Issue 10, 2011, Pages 683-690

  Figarella Branger, D ^a,b,c,d   Maues De Paula, A ^a,d   Colin, C ^b,c,d   Bouvier, C ^a,b,c,d  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

1p19q codeletion; Adult gliomas; IDH mutation; Immunohistochemistry; Molecular markers; TP53 mutation

Indexed keywords

PROTEIN P53;

ARTICLE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER GRADING; DIAGNOSTIC VALUE; GENE MUTATION; GLIOBLASTOMA; GLIOMA; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIOMA; PROGNOSIS; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; CELL LINEAGE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 81955160742     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.07.006     Document Type: Article

References (54)

1. L. Anker, H. Ohgaki, B.I. Ludeke, H.D. Herrmann, P. Kleihues, and M. Westphal p53 protein accumulation and gene mutations in human glioma cell lines Int J Cancer 55 1993 982 987
2. J. Balss, J. Meyer, W. Mueller, A. Korshunov, C. Hartmann, and A. von Deimling Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol 116 2008 597 602
3. S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, and R.E. McLendon Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res 68 2008 6043 6048
4. C. Bouvier, C. Bartoli, L. Aguirre-Cruz, I. Virard, C. Colin, and C. Fernandez Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells J Neurosurg 99 2003 344 350 (Pubitemid 36903275)
5. J.G. Cairncross, K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, and R.R. Hammond Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1998 1473 1479 (Pubitemid 28482012)
6. D. Capper, H. Zentgraf, J. Balss, C. Hartmann, and A. von Deimling Monoclonal antibody specific for IDH1 R132H mutation Acta Neuropathol 118 2009 599 601
7. S.O. Chan, and F.C. Chiu Cloning and developmental expression of human 66 kd neurofilament protein Brain Res Mol Brain Res 29 1995 177 184
8. C. Colin, N. Baeza, S. Tong, C. Bouvier, B. Quilichini, and P. Durbec In vitro identification and functional characterization of glial precursor cells in human gliomas Neuropathol Appl Neurobiol 32 2006 189 202
9. C. Colin, I. Virard, N. Baeza, A. Tchoghandjian, C. Fernandez, and C. Bouvier Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis Neuropathol Appl Neurobiol 33 2007 431 439 (Pubitemid 47037890)
10. S.W. Coons, P.C. Johnson, B.W. Scheithauer, A.J. Yates, and D.K. Pearl Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas Cancer 79 1997 1381 1393 (Pubitemid 27143246)
11. B. Coulibaly, I. Nanni, B. Quilichini, J. Gaudart, P. Metellus, and F. Fina Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression Hum Pathol 41 2010 815 823
12. C. Daumas-Duport, M.L. Tucker, H. Kolles, P. Cervera, F. Beuvon, and P. Varlet Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria J Neurooncol 34 1997 61 78 (Pubitemid 27270252)
13. C. Daumas-Duport, F. Beuvon, P. Varlet, and C. Fallet-Bianco Gliomas: WHO and Sainte-Anne Hospital classifications Ann Pathol 20 2000 413 428
14. F. Ducray, A. Idbaih, A. de Reynies, I. Bieche, J. Thillet, and K. Mokhtari Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile Mol Cancer 7 2008 41
15. D. Figarella-Branger, C. Colin, B. Coulibaly, B. Quilichini, A. Maues De Paula, and C. Fernandez Histological and molecular classification of gliomas Rev Neurol (Paris) 164 2008 505 515 (Pubitemid 351893098)
16. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, and S. De Vitis Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res 64 2004 7011 7021 (Pubitemid 39331011)
17. C. Hartmann, B. Hentschel, W. Wick, D. Capper, J. Felsberg, and M. Simon Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas Acta Neuropathol 120 2010 707 718
18. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, and M. Kujas Two types of chromosome 1p losses with opposite significance in gliomas Ann Neurol 58 2005 483 487 (Pubitemid 41266639)
19. R.B. Jenkins, H. Blair, K.V. Ballman, C. Giannini, R.M. Arusell, and M. Law A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma Cancer Res 66 2006 9852 9861 (Pubitemid 44672036)
20. M.T. Jennings, M. Frenchman, T. Shehab, M.D. Johnson, J. Creasy, and K. LaPorte Gliomatosis cerebri presenting as intractable epilepsy during early childhood J Child Neurol 10 1995 37 45
21. Y.H. Kim, S. Nobusawa, M. Mittelbronn, W. Paulus, B. Brokinkel, and K. Keyvani Molecular classification of low-grade diffuse gliomas Am J Pathol 177 2010 2708 2714
22. J.M. Kros, T. Gorlia, M.C. Kouwenhoven, P.P. Zheng, V.P. Collins, and D. Figarella-Branger Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome J Neuropathol Exp Neurol 66 2007 545 551 (Pubitemid 46869696)
23. M. Labussiere, A. Idbaih, X.W. Wang, Y. Marie, B. Boisselier, and C. Falet All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 Neurology 74 2010 1886 1890
24. K.L. Ligon, E. Huillard, S. Mehta, S. Kesari, H. Liu, and J.A. Alberta Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma Neuron 53 2007 503 517 (Pubitemid 46216748)
25. D.N. Louis, A. von Deimling, R.Y. Chung, M.P. Rubio, J.M. Whaley, and R.H. Eibl Comparative study of p53 gene and protein alterations in human astrocytic tumors J Neuropathol Exp Neurol 52 1993 31 38 (Pubitemid 23016637)
26. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, and A. Jouvet The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109 (Pubitemid 47103521)
27. Y. Marie, M. Sanson, K. Mokhtari, P. Leuraud, M. Kujas, and J.Y. Delattre OLIG2 as a specific marker of oligodendroglial tumour cells Lancet 358 2001 298 300 (Pubitemid 32738972)
28. P. Metellus, B. Coulibaly, C. Colin, A.M. de Paula, A. Vasiljevic, and D. Taieb Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis Acta Neuropathol 120 2010 719 729
29. P. Metellus, I. Nanni-Metellus, C. Delfino, C. Colin, A. Tchogandjian, and B. Coulibaly Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution Ann Surg Oncol 2011 [Epub ahead of print]
30. C.R. Miller, C.P. Dunham, B.W. Scheithauer, and A. Perry Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas J Clin Oncol 24 2006 5419 5426 (Pubitemid 46623175)
31. K. Mokhtari, F. Ducray, J.M. Kros, T. Gorlia, A. Idbaih, and M. Taphoorn Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951 Cancer 117 2011 3014 3026
32. W. Mueller, C. Hartmann, A. Hoffmann, W. Lanksch, J. Kiwit, and J. Tonn Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets Am J Pathol 161 2002 313 319 (Pubitemid 34760797)
33. E.W. Newcomb, W.J. Madonia, S. Pisharody, F.F. Lang, M. Koslow, and D.C. Miller A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme Brain Pathol 3 1993 229 235 (Pubitemid 23276689)
34. Y. Okamoto, P.L. Di Patre, C. Burkhard, S. Horstmann, B. Jourde, and M. Fahey Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas Acta Neuropathol 108 2004 49 56 (Pubitemid 38961073)
35. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, and P. Angenendt An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
36. A. Peraud, F.W. Kreth, O.D. Wiestler, P. Kleihues, and H.J. Reulen Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas Clin Cancer Res 8 5 2002 1117 1124 (Pubitemid 34517648)
37. A.I. Persson, C. Petritsch, F.J. Swartling, M. Itsara, F.J. Sim, and R. Auvergne Non-stem cell origin for oligodendroglioma Cancer Cell 18 2010 669 682
38. H.S. Phillips, S. Kharbanda, R. Chen, W.F. Forrest, R.H. Soriano, and T.D. Wu Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 2006 157 173 (Pubitemid 43357943)
39. R.A. Prayson, D.P. Agamanolis, M.L. Cohen, M.L. Estes, B.K. Kleinschmidt-DeMasters, and F. Abdul-Karim Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading J Neurol Sci 175 2000 33 39 (Pubitemid 30227481)
40. G. Reifenberger, D.N. Louis, and Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology J Neuropathol Exp Neurol 62 2003 111 126 (Pubitemid 36176946)
41. M.J. Riemenschneider, and G. Reifenberger Molecular neuropathology of gliomas Int J Mol Sci 10 2009 184 212
42. J. Schlegel, A. Merdes, G. Stumm, F.K. Albert, M. Forsting, and N. Hynes Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma Int J Cancer 56 1994 72 77 (Pubitemid 24044796)
43. M. Seiz, J. Tuettenberg, J. Meyer, M. Essig, K. Schmieder, and C. Mawrin Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes Acta Neuropathol 120 2010 261 267
44. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, and T. Hide Identification of human brain tumour initiating cells Nature 432 2004 396 401 (Pubitemid 39551674)
45. J.S. Smith, A. Perry, T.J. Borell, H.K. Lee, J. O'Fallon, and S.M. Hosek Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas J Clin Oncol 18 2000 636 645 (Pubitemid 30078545)
46. M. Stander, A. Peraud, B. Leroch, and F.W. Kreth Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis Cancer 101 2004 1028 1035 (Pubitemid 39100437)
47. A. Tchoghandjian, N. Baeza, C. Colin, M. Cayre, P. Metellus, and C. Beclin A2B5 cells from human glioblastoma have cancer stem cell properties Brain Pathol 20 2010 211 221
48. M.J. Van den Bent, A.F. Carpentier, A.A. Brandes, M. Sanson, M.J. Taphoorn, and H.J. Bernsen Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial J Clin Oncol 24 2006 2715 2722 (Pubitemid 46630567)
49. R.G. Verhaak, K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, and M.D. Wilkerson Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110
50. A. von Deimling, A. Korshunov, and C. Hartmann The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations Brain Pathol 21 2011 74 87
51. T. Watanabe, M. Nakamura, J.M. Kros, C. Burkhard, Y. Yonekawa, and P. Kleihues Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas Acta Neuropathol 103 2002 267 275 (Pubitemid 36075328)
52. T. Watanabe, S. Nobusawa, P. Kleihues, and H. Ohgaki IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Am J Pathol 174 2009 1149 1153
53. H. Yan, D.W. Parsons, G. Jin, R. McLendon, B.A. Rasheed, and W. Yuan IDH1 and IDH2 mutations in gliomas N Engl J Med 360 2009 765 773
54. F. Zeppernick, R. Ahmadi, B. Campos, C. Dictus, B.M. Helmke, and N. Becker Stem cell marker CD133 affects clinical outcome in glioma patients Clin Cancer Res 14 2008 123 129 (Pubitemid 351377986)